Galectin-3 (Gal-3), a pleiotropic B-galactoside-binding protein, was shown to be involved in several nuclear-dependent functions, including up-regulation of transcriptional factors, RNA processing, and cell cycle regulation. Gal-3 compartmentalization in the nucleus versus the cytoplasm affects, in part, the malignant phenotype of various cancers. However, to date, the mechanism by which Gal-3 translocates into the nucleus remains debatable. Thus, we have constructed and expressed a variety of fusion proteins containing deletion mutants of Gal-3 fused with monomers, dimers, and trimers of enhanced green fluorescent protein and searched for the Gal-3 sequence motifs essential for its nuclear localization in vivo. In addition, a digitonin-permeabilized, cell-free transport in vitro assay was used to directly examine the mechanism of Gal-3 nuclear import. Partial deletions of the COOH-terminal region (114-250) of the human Gal-3 significantly decreases its nuclear translocation, whereas a peptide (1-115) was transported to the nuclei. The in vitro nuclear import assay revealed that there are at least two independent nuclear pathways for shuttling Gal-3 into the nucleus: a passive diffusion and an active transport. This is the first article providing direct evidence for the nuclear import mechanisms of Gal-3 and suggests that Gal-3 nuclear translocation is governed by dual pathways, whereas the cytoplasmic/nuclear distribution may be regulated by multiple processes, including cytoplasmic anchorage, nuclear retention, and or nuclear export. These results may lead to the development of a therapeutic modality aiming at abrogating Gal-3 translocation into the nucleus and thus hampering its activity during cancer progression and metastasis.
Introduction
Galectins are an evolutionarily conserved family of h-galactosidebinding proteins that exhibit diverse biological activities (1, 2) . These proteins contain at least one carbohydrate recognition domain (CRD) of f130 amino acid residues with significant sequence homology and are categorized into three major groups: the prototype, the chimera type, and the tandem repeat type (3) .
Galectin-3 (Gal-3), the sole chimera type of galectin, is expressed ubiquitously and is involved in cell proliferation, cell-cell interaction, and cell-matrix adhesion mainly through binding to glycoproteins (2, 4, 5) . In particular, nuclear Gal-3 is presumably associated with normal cell proliferation because it is a required splicing factor interacting with Gemin4 (5, 6) . In cancer, the loss of nuclear Gal-3 expression is associated with tumor progression of colon, prostate, and squamous carcinoma cells of the tongue carcinoma (7) (8) (9) . In lung carcinoma, the specific expression of nuclear Gal-3 is a predictive factor of recurrence and/or a worse clinical outcome (10, 11) . In patients with esophageal squamous cell carcinoma, elevated expression of Gal-3 in the nuclei is an important biological variable related to histologic differentiation and vascular invasion (12) . In an experimental prostate cancer model system, nuclear Gal-3 suppressed malignancy whereas cytoplasmic Gal-3 promoted tumorigenicity (13) . In the nuclei of papillary thyroid cancer cells, Gal-3 interacts with the thyroidspecific TTF-1 transcription factor and up-regulates its transcriptional activity, contributing to the proliferation of the thyroid cells (14) . In human breast epithelial cells, Gal-3 translocation into the nucleus exerts a growth-promoting effect by the induction of cyclin D1 expression through enhancement or stabilization of the nuclear protein-DNA complex formation of the cyclin D1 promoter (15) . Gal-3 is a novel binding partner regulating h-catenin shuttling to the nucleus, and the Gal-3-h-catenin complex activates Tcfreporter activity and stimulate cyclin D1 and c-myc (16, 17) .
Despite the above, the mechanism of how Gal-3 is imported to the nucleus remains unclear, as it lacks classic nuclear localization signal (NLS; refs. 18, 19) , whereas the nuclear export mechanism of Gal-3 is better characterized (20) . Previously, it was reported that deletion of the first 11 amino acid residues of Gal-3, which contains a serine phosphorylation site, leads to a predominant cytoplasmic distribution (21) , whereas others showed that an NH 2 -terminal deletion mutant of hamster Gal-3 could be localized in the nucleus even when up to 103 amino acid residues were deleted (22) . The COOH-terminal deletion mutant of mouse Gal-3 lost its nuclear localization, suggesting that Gal-3 nuclear import was dependent on the IXLT type NLS, residing in the end of COOH-terminal region (23) . Here, we show that the deletion mutant of the last 10 amino acids from the COOH terminus of the human Gal-3 (1-240) resulted in the abrogation of nuclear accumulation, whereas deletion mutant of the entire CRD (1-115) did not. The in vitro analyses provide direct evidence that Gal-3 can migrate into the nucleus by at least two distinct pathways: either by passive diffusion or by an active transport system. a 3 ¶ primer for aa 1-150 (1-150/G), 5 ¶-GGGGTACCTTGGAAATCTAAAGCA-3 ¶; a 3 ¶ primer for aa 1-175 (1-175/G), 5 ¶-GGGGTACCTGTATTGCAAACAATG-3 ¶; a 3 ¶ primer for aa (1-200/G), 5 ¶-GGGGTACCTATTTTGAATGGTTTC-3 ¶; a 3 ¶ primer for aa 1-222 (1-222/G), 5 ¶-GGGGTACCATTGTACTGCAACAA-3 ¶; a 3 ¶ primer for aa 1-229 (1-229/G), 5 ¶-GGGGTACCATTGAGTTTTTTAAC-3 ¶; a 3 ¶ primer for aa 1-240 (1-240/G), 5 ¶-GGGGTACCTATGTCACCAGAAATTC-3 ¶; a 3 ¶ primer for aa 1-245 (1-245/G), 5 ¶-GGGGTACCAGCACTGGTGAGGTCTA-3 ¶; a 5 ¶ primer for above all frames, 5 ¶-CGGAATTCGCGGAAAATGGCAGA-3 ¶]; and then subcloned into pEGFP-N3 vector (BD Bioresearch, Palo Alto, CA) after digesting with BamHI or KpnI and EcoRI. For the constructs of two deletions [deletion of aa 136-238 (D136-238) and aa 230-238 (D230-238)], the fragment of aa 239 to the end of EGFP ( f239EGFP) was amplified using 1-250/ G as a template with a set of primers (a 5 ¶ primer, 5 ¶-GGGGTACCGACATA-GACCTCA-3 ¶; a 3 ¶ primer, 5 ¶-TGATCTAGAGTCGCGGCCGCTTT-3 ¶); and then subcloned into 1-135/G and 1-229/G, respectively, after digesting with KpnI and NotI. For the NH 2 -terminal deletion [deletion of aa 1-113 (G/114-250)], the fragment of EGFP ( fEGFP) was first amplified using pEGFP-N3 as a template with a set of primers (a 5 ¶ primer, 5 ¶-CGGGATCCATCGCCAC-CATGGT-3 ¶; a 3 ¶ primer, 5 ¶-CGGGATCCCTTGTACAGCTCGTC-3 ¶), and subcloned into pcDNA3.1/myc-His B after digesting with BamHI, creating sense direction of Â1GFP [Â1GFP/His(s)], antisense direction of Â1GFP [Â1GFP/His(as)], and Â2GFP [Â2GFP/His(as)] vectors. Next, the fragment for aa 114 to 250 of Gal-3 was amplified with a set of primers (a 5 ¶ primer, 5 ¶-CGGAATTCTCTGATTGTGCCTTATAACC-3 ¶; a 3 ¶ primer, 5 ¶-CCGGGCCCGATATCATGGTATATG-3 ¶), and subcloned into Â1GFP/His(s) after digesting with EcoRI and ApaI. To create the constructs for Gal-3 and its deletion derivatives fused with dimer to tetramer of EGFP (Â2 to Â4GFP), the following procedures were done. To construct the expression vector of wildtype Gal-3 fused with 2EGFP (1-250/Â2G), the fEGFP was inserted into 1-250/ G with sense direction. For wild-type Gal-3 fused with Â3EGFP (1-250/Â3G), the fragment from Â1GFP/His(s) cut with HindIII/EcoRI was inserted into (1-250/Â2G) vector. Next, to make the expression vector of Â2GFP, the fEGFP was inserted into pEGFP-N3. The fragment from Â1GFP/His(s) cut with HindIII/EcoRI, and from Â1GFP/His(as) cut with EcoRI/KpnI was inserted into Â2GFP, respectively, creating Â3GFP(a) and Â3GFP(b) vectors. For Â4GFP vector, the fragment from Â2GFP/His(as) cut with EcoRI/KpnI was inserted into Â2GFP. Thereafter, to create the constructs for deletions (aa 1-115, aa 114-250, and aa 239-250) fused with Â3EGFP (1-115/Â3G, 114-250/Â3G, and 239-250/Â3G), the fragment from 1-115/G cut with EcoRI/ KpnI, G/114-250 cut with EcoRI/ApaI, and the f239EGFP was subcloned into Â3GFP(a) and Â4GFP, respectively. For the construct of other deletions (aa 139-193, aa 139-250) fused with Â3EGFP (139-193/Â3G, 139-250/Â3G), the fragments amplified by a PCR using a set of primers (a 5 ¶ primer for both, 5 ¶-GGGGTACCAAGCCCAATGCAAACA-3 ¶; a 3 ¶ primer for 139-193, 5 ¶-CCGGGCCCGCTTCAAATGGGAAAA-3 ¶; a 3 ¶ primer for 139-250, 5 ¶-CCGGGCCCGATATCATGGTATATG-3 ¶) were cut with KpnI/ApaI, followed by subcloning into Â3GFP(b), respectively.
To create the constructs for wild-type Gal-3 and its deletion mutant fused with polypeptide of SV40 T-antigen NLS (PPKKKRKVEDP), the following procedures were done. First, the fragment cut with BamHI/EcoRI from pGEX-2T-SV40 NLS-GFP (kindly provided by Dr. Yoshihiro Yoneda) was subcloned into pcDNA3.1/His C (Invitrogen, Carlsbad, CA) to create the vector, Â1GFP/His-NLS. To create the expression vector of NLS+Â2GFP, fEGFP was inserted into Â1GFP/His-NLS with sense direction. For the constructs of wild-type and deletion mutant (aa 1-222) fused with SV40NLS and Â2GFP (1-250+NLS+Â2GFP, 1-222+NLS+Â2GFP), the fragment from Â1GFP/His-NLS cut with BamHI/NotI was subcloned into the vector, 1-250/G and 1-222/G, respectively, followed by insertion of fEGFP in the sense direction. For the construct of wild-type Gal-3 fused with SV40NLS and Â3GFP (1-250+NLS+Â3GFP), the fragment from the vector, 1-250+NLS+Â2GFP, cut with EcoRI, was inserted into Â1GFP/His(s) in the sense direction.
To create expression vectors for nuclear export signal (NES) fused with Â2EGFP, another Â2GFP vector (Â2GFP/His) was constructed by subcloning the fragment cut with HindIII/ApaI from Â1GFP/His(s) into pEGFP-N3. Two sets of synthesized oligonucleotides ( for p53 NES2, 5 ¶-AATTCTGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAG-GATTCGGGCC-3 ¶ and 5 ¶-CGAATCCTTGAGTTCCAAGGCCTCATT-CAGCTCTCGGAACATCTCAG-3 ¶, and for Gal-3 NES, 5 ¶-AATTCTCTC-AATGAAATCAGCAAACTGGGAATTTCGGGCC-3 ¶ and 5 ¶-CGAAATTCCCA-GTTTGCTGATTTCATTGAGAG-3 ¶) were annealed as described previously (21) , and treated with T4 polynucleotide kinase (Promega, Madison, WI) according to the protocol of the manufacturer. These annealed oligonucleotides were subcloned into Â2GFP/His after digesting with EcoRI and Apa I, creating the expression vectors p53NES2+Â2GFP and Gal-3NES+Â2GFP, respectively.
Plasmid construction for expression in bacteria. The construct for expression of wild-type Gal-3 in a glutathione S-transferase (GST) gene fusion vector pGEX-6p-2 (Amersham, Piscataway, NJ) was described previously (24) . This vector is called the pGEX/Gal-3. To create the constructs for wild-type Gal-3 fused with Â1EGFP in a GST fusion system (pGEX/Gal-3/GFP), the fragment from 1-250/G vector cut with EcoRI/NotI was subcloned into the vector pGEX-6p-3. For the construction of Â1EGFP in a GST fusion system (pGEX/Â1GFP), the larger fragment from pGEX/ Gal-3/GFP cut with BamHI was self-ligated. To construct the expression vectors of the pGEX/1-115/Â2GFP and pGEX/139-193/GFP, the fragments from (139-193/Â3G) cut with EcoRI/NotI and from (1-115/Â3G) cut with BamHI were subcloned into the vectors pGEX-6p-3 and pGEX/Â1GFP, respectively, in the sense direction. The expression vectors of pGEX-2T-SV40 NLS-GFP and pGEX-HA-PTAC97 (importin-h) were kindly provided by Dr. Yoshihiro Yoneda, and to create the construct of importin-h fused with Â1EGFP (GFP/imp-h), fEGFP was inserted into pGEX-HA-PTAC97 vector in the sense direction. The expression plasmid of pGEX-CAN(FG-repeat) derived from CAN/Nup214 was constructed as described previously (25) .
Transfection. To express the proteins in cultured cells, a variety of plasmids for Gal-3 deletion mutants were transfected into COS-7 and BT549 cells using LipofectAMINE 2000 reagent (Invitrogen). Transfection mixtures were prepared according to the instructions of the manufacturer. Leptomycin B (LMB; Sigma, St. Louis, MO) was used in part of the experiments at concentration of 30 ng/mL for 6 hours at 37jC after transfection.
Western blotting. To confirm the protein expression, the plasmidtransfected COS-7 cells were collected and processed as described (26) .
Fluorescence microscopy. To detect the GFP expression in the plasmidtransfected cells, cells on the chamber slide were fixed with 4% paraformaldehyde in PBS for 20 minutes at 24 hours after transfection. The cells were then washed with PBS and counterstained with 5 Ag/mL Hoechst 33258 (Molecular Probes, Eugene, OR). After washing extensively with PBS, the cells were mounted in 80% glycerol and analyzed using an Olympus BX40 microscope and MCID software.
In vitro nuclear import assay. Digitonin-permeabilized HeLa cells were prepared as described previously (27) (28) (29) . The reaction for nuclear import assay was done in 10 AL testing solution containing the substrates dissolved in transport buffer [20 mmol/L HEPES (pH 7.3), 110 mmol/L potassium acetate, 2 mmol/L magnesium acetate, 5 mmol/L sodium acetate, 0.5 mmol/L EGTA, 2 mmol/L DTT, 1 Ag/mL aprotinin, leupeptin, and pepstatin A]. The composition and concentration of the recombinant proteins are described in each figure legend. Where indicated, an ATPregenerating system (1 mmol/L ATP, 5 mmol/L phosphocreatine, 20 units creatine kinase; Sigma) and/or cytosol prepared from HeLa cells (28) were included in the above 10 AL testing solution. For wheat germ agglutinin (WGA) or antibody treatment, 4 Ag WGA (Sigma) or 2 Ag purified anti-Gal-3 polyclonal antibody was contained in the testing solution. The import reaction was done for 30 minutes at 30jC or 4jC, and the cells were then washed with ice-cold transport buffer and fixed with 4% paraformaldehyde/ 2% sucrose/PBS for 20 minutes at room temperature, followed by staining with Hoechst 33258 (Molecular Probes).
In vitro binding assay. We have followed the protocol as described previously (25) . deletion polypeptides were constructed and expressed in mammalian cells (Fig. 1A) . The cDNAs were tagged with EGFP (see Materials and Methods) to enable the subcellular visualization of the proteins following transfection into COS-7 cells. To confirm the correct expression of the deletion mutants of EGFP-fused Gal-3, Western blotting of the transfected COS-7 cell lysates was done using antibodies directed against GFP and Gal-3 (Fig. 1B) . All of the Gal-3 mutant plasmids expressed proteins of the predicted molecular weights as shown in the GFP Western blotting of Fig. 1B, I , with identical molecular weight bands revealed by the Western blotting of Gal-3, indicating correct expression of mutated/deleted Gal-3 polypeptides (Fig. 1B, II) . Next, after establishing expression of the Gal-3 polypeptides, their subcellular distribution in COS-7 cells was analyzed under fluorescence microscopy 24 hours after transfection; following fixation and permeabilization, the cells were counterstained with Hoechst 33258 to clearly define the nuclear areas. A representative image of the subcellular localization for each mutant of Gal-3 in transfected COS-7 cells is depicted in Fig. 1C . Because some of the peptide expression patterns were heterogeneous, their distribution were categorized as follows: predominantly localized in the nucleus (N > C), equally localized throughout the nucleus and the cytoplasm (N = C), mostly localized in the cytoplasm, or spotted around the nucleus (N < C).
Wild-type Gal-3 EGFP-fused protein (1-250/G) and its dimer protein (Â2GFP) are randomly distributed between the nucleus and the cytoplasm compartments of >70% and >80% of transfected cells, respectively, whereas the fluorescent intensity of 1-250/G in the nucleus was clearly higher than the one of Â2GFP (Fig. 1C , a, b), indicating that Gal-3 translocated to the nucleus. In COS-7 cells transfected with a plasmid encoding 1-245/G, the nuclear fluorescent in the nucleus was decreased compared with 1-250/G and was localized in the cytoplasm in district patchy-like foci in f23% of the transfected cells (Fig. 1C , c) Additional deletion of five amino acids (1-240/G) resulted in a complete abrogation nuclear staining associated with high intensity in a patchy pattern throughout the cytoplasm (Fig. 1C, d ) typical for >95% of the transfected cells. In COS-7 cells transfected with the plasmid of 1-222/G, similar fluorescent speckles were observed in the perinuclear region of 99% of the transfected cells (Fig. 1C, e) . However, the distribution expression pattern of the other deletion mutant proteins, e.g., 1-200/G, 1-175/G, 1-150/G, or 1-135/G, in which a partial CRD region of Gal-3 still remained, showed two opposite cellular distributions: one is the pattern of predominant nuclear localization and the other is entire cytoplasmic localization (Fig. 1C, f, g ). On the other hand, the 1-115/G polypeptide, devoid of the CRD, was found to exhibit the highest affinity to the nucleus, but not the nucleoli (Fig. 1C, h) , typical for f85% of the transfected cells. Of note, the monomer EGFP (Â1GFP) was found to be randomly diffusely distributed throughout the cell, including the nucleoli (Fig. 1C, i) , implying that the first 115 amino acids of Gal-3 harbor a motif that regulates its nuclear transport. In contrast, deletion of complete NH 2 -terminal region of Gal-3 and fusing it with EGFP (G/114-250) resulted in a peptide that distributed throughout the cell, including the nuclear area of >70% of the transfected cells (Fig. 1C, l) , indicating that Gal-3 can be translocated into the nucleus without its NH 2 -terminal region as described previously (22) . These results may suggest that Gal-3 can be imported into the nucleus only with its COOH-terminal region (CRD). In particular, the last 10 amino acids (241-250) are required for its nuclear localization. Next, to address the possibility that the last 10 amino acids include the signal sequence for Gal-3 nuclear localization, we created two constructs for Gal-3 deletion mutants, in which the nucleotides for 136 to 238 and 230 to 238 amino acids of Gal-3 were deleted ( Fig. 1A ; D136-238, D230-238), and expressed these plasmids correspondingly. As shown in Fig. 1C , k, l, the expression patterns of these proteins were similar to that of 1-135/ G and 1-222/G, respectively, suggesting that the terminal 12 amino acids were not involved in the nuclear transport of Gal-3.
It might be argued that the above results might be due to differences in the diffusion coefficient rather than active transport, because 1-250/G or Â2GFP (f60 kDa) polypeptides are small enough to be distributed throughout the nucleus and cytoplasm by passive diffusion (30) (31) (32) . Therefore, to identify the region responsible for the NPC passage of Gal-3 protein, deletion derivatives of Gal-3 were constructed and fused with dimer or trimer of EGFP (Â2GFP, Â3GFP) as depicted in Fig. 2A . Western blotting of the transfected COS-7 cell lysates was done using antibodies to GFP (Fig. 2B, I ) and Gal-3 (Fig. 2B, II) . All Gal-3 mutant plasmids expressed proteins with the expected molecular mass (Fig. 2B, I, II) . Thereafter, COS-7 and BT549 cells were transfected with these plasmids, and the distribution of the EGFPfused Gal-3 deletion mutants was analyzed as described above. The representative pattern of each mutant in transfected COS-7 cells is shown in Fig. 2C .
The expression of Â3GFP as well as Â4GFP was distributed in the cytoplasm (Fig. 2C, a, b) . This pattern was typical for f46% and 80% of the transfected COS-7 cells, respectively. The wild-type Gal-3 fused with Â2EGFP (1-250/Â2G), of which the molecular mass is almost same as Â3GFP, was localized throughout the cell, including the nuclear area in >67% of the transfected COS-7 cells (Fig. 2C, c) , implying that Gal-3 was transported into the nucleus by an active transport system and not simply by a passive diffusion. The expression of wild-type Gal-3 fused with Â3EGFP (1-250/Â3G) could be detected in the cytoplasm in a patchy vesicular pattern and weakly in the nucleus in f88% of the transfected COS-7 cells (Fig. 2C, d) , whereas the 1 to 115 amino acid peptide fused with Â3EGFP (1-115/Â3G) was localized predominantly in the nucleus (Fig. 2C, e) of >30% of the transfected cells, supporting the suggestion of an active involvement of the NH 2 -terminal region in Gal-3 nuclear transport. In contrast, a peptide constructed from the 114 to 250 amino acids of Gal-3 fused with Â3EGFP (114-250/Â3G) remained entirely in the cytoplasm of transfected COS-7 cells (Fig.  2C, f ) . Similarly, the expression of 139 to 250 or 239 to 250 amino acid peptides of Gal-3 fused with Â3EGFP (139-250/Â3G, 239-250/ Â3G) were diffused thought the cytoplasm (Fig. 2C, g, h) . These predominant cytoplasmic patterns are typical for >50% of the transfected cells. However, the expression pattern of 139 to 193 amino acid peptide of Gal-3 fused with Â3EGFP (139-193/Â3G) showed a nuclear localization (Fig. 2C, i) in 34% of the transfected cells. In the case of expression in BT549 cells, distribution patterns were similar to the results in COS-7 cells (not shown). These results indicate that Gal-3 is actively translocated into the nucleus.
Conjugation of SV40 T-antigen NLS can rescue the nuclear accumulation of impaired Gal-3. Gal-3 does not contain a consensus NLS, needed for the importin-mediated nuclear import pathway (18, 19) . Previously, it was reported that Gal-3 may be localized in the nucleus following insertion into pCMV/myc/nuc vector, which is designed for specific expression of the protein in the nucleus (13) . Therefore, we questioned the nuclear translocation of impaired Gal-3, such as 1-222/G or 1-250/Â3G, following conjugation to the classic NLS and constructed plasmids containing SV40 T-antigen NLS sequence as depicted in Fig. 3A , transfect them, and followed their expression in COS-7 cells. Western blotting revealed that all transfected COS-7 cell lysates used expressed proteins with the predicted molecular mass (Fig.  3B) . A representative expression pattern of the proteins in transfected COS-7 cells is depicted in Fig. 3C and the relative proportion of the distinct subcellular localization was calculated and plotted in Fig. 3D .
As expected, the expression of Â2GFP with SV40NLS (NLS+Â2GFP) was exclusively restricted to the nucleus (Fig. 2C, a) , in >95% of the transfected cells (Fig. 2D) , indicating that this fusion protein contains a bona fide NLS and may be used in confidence to analyze the Gal-3 peptides. The expression of all Gal-3 derivatives fused with SV40 T-antigen NLS (1-222+NLS+Â2GFP, 1-250+NLS+Â2GFP, 1-250+NLS+Â3GFP) was exclusively localized to the nucleus (Fig. 3C, b-d) . These results indicate that in Gal-3, the impaired nuclear translocation of deleted or larger size of Gal-3 polypeptides was not due to the loss of the NLS.
Nuclear import of Gal-3 in digitonin-permeabilized cells. To provide a direct evidence for the Gal-3 nuclear import pathway of Gal-3, we have adopted the digitonin-permeabilized, cell-free transport assay (27, 28) , a methodology commonly used to establish the mechanism of nuclear import of nucleoproteins like h-catenin, importin-h, and mitogen-activated protein kinase (MAPK; refs. 25, 
29, 33
). Initially, we tested whether the in vitro assay system would accurately function when using well-characterized substrates, such as GFP-fused SV40 T-antigen NLS polypeptides (GST/NLS/GFP) or importin-h (GFP/imp-h; refs. 25, 26, 29, 33) . In addition, monomer EGFP was used as a positive control substrate and fluorescenceconjugated bovine serum albumin (F/BSA) was used as a negative control substrate for passive diffusion (25, 26) . The complete in vitro assay system consisted of digitonin-permeabilized HeLa cells, cytosol extracts of HeLa cells (''cytosol''), and the ATP-regenerating system ('' ATP''). Digitonin-permeabilized HeLa cells were incubated in the testing solution (10 AL), including the import substrate with or without cytosol, ATP, and WGA, an inhibitor of molecules passing through the NPC, for 30 minutes at 30jC. At the end of incubation, cells were fixed and stained with Hoechst 33258 to define the nuclear areas.
As reported previously (26, 33) , GST/NLS/GFP can be imported into the nucleus under these conditions (Fig. 4A, a) , whereas either depletion of cytosol or the addition of WGA abrogates its nuclear accumulation (Fig. 4A, g, m) and confirmed that GFP/imp-h can be translocated into the nucleus irrespective of cytosol depletion, and can be inhibited by the addition of WGA (Fig. 4A, h, n) . We also confirmed that the addition of cytosol did not stimulate but rather inhibit import of GFP/imp-h as reported previously (Fig. 4A, b) . GFP can migrate into the nucleus even when WGA was added in the testing solution (Fig. 4A, c, i, o) , as reported previously (25) . F/ BSA was not fully imported into the nucleus under any of the tested conditions (Fig. 4A, f, l) . Thus, the in vitro nuclear assay system used here mimics those reported previously (25, 26, 29, 33) . Thereafter, EGFP-fused Gal-3 (Gal-3/GFP) and fluorescence-labeled Gal-3 (F/Gal-3) were tested in this in vitro nuclear import assay. However, both Gal-3/GFP and F/Gal-3 accumulated on the cell surface with or without cytosol and never migrated into the nucleus under these conditions (Fig. 4A, d, e, j, k) . This accumulation of exogenous Gal-3 on the cell surface implies that the binding of Gal-3 to the cell surface glycoprotein receptors inhibit its free diffusion. Thus, we added a specific Gal-3 sugarbinding inhibitor, i.e., lactose, to the reaction mixture (50 mmol/L) and repeated the in vitro assay. In this modified condition, both GFP/Gal-3 and F/Gal-3 were able to effectively migrate into the nucleus (Fig. 4B, c, d) , whereas the addition of the control sugar, i.e., sucrose (50 mmol/L), did not change the distribution pattern (Fig. 4B, a, b) . Moreover, GFP/Gal-3 could not efficiently accumulate in the nucleus without cytosol (Fig. 4B, g ) and its nuclear accumulation was completely inhibited by addition of WGA (Fig. 4B, i) , whereas F/Gal-3 could freely migrate into the nucleus without cytosol even when WGA was added in the testing solution (Fig. 4B, h, j) . These results suggest that wild-type Gal-3 can either migrate into the nucleus by passive diffusion while maintaining an active transport mechanism for its NPC passage. Because F/Gal-3 can migrate into the nucleus in the presence of WGA (Fig. 4B, j) , it is reasonable to assume that wild-type Gal-3 can enter the nucleus, in part, by passive diffusion. To confirm this, we examined whether F/Gal-3 and Gal-3/GFP enter the nucleus by performing the in vitro assay at 4jC, whereby the active nuclear import pathway is Galectin-3 and Nuclear Import www.aacrjournals.org completely inhibited (26, 33) , and added 50 mmol/L lactose to the reaction mixture that was incubated at 4jC for 30 minutes. GFP was used as a positive control and GFP/imp-h was used as a negative control. Consistent with the result of the WGA inhibition, F/Gal-3 (Fig. 4C, c) and GFP (Fig. 4C, a) were able to diffuse into the nucleus at 4jC, whereas Gal-3/GFP (Fig. 4C, b) and GFP/imp-h did not (data not shown). This nuclear accumulation of F/Gal-3 is effectively blocked by purified polyclonal antibody against Gal-3 (Fig. 4C, d) , thus supporting the finding that F/Gal-3 can enter the nucleus by passive diffusion, attesting to the specificity of the experimental system used here and suggesting that endogenous Gal-3 can migrate into the nucleus, in part, by passive diffusion.
NH 2 -terminal region of Gal-3 has active nuclear transport capacity without ATP and any soluble factors. Because Gal-3/ GFP could enter the nucleus in vitro in the presence of lactose (Fig.  4B, c) , whereas its nuclear migration was inhibited by WGA that binds to the nucleoporin in the NPC and thus inhibits passages through the NPC (Fig. 4B, i) or at 4jC (Fig. 4C, b) , it is highly unlikely that it migrates into the nucleus by a passive diffusion. The results obtained from the transfection experiments using Gal-3 deletion mutants fused with EGFP indicate that the domain(s) responsible for Gal-3 protein nuclear localization is in part in the NH 2 -terminal half (1-115) and in part on its core COOH-terminal region (139-193). Therefore, 1 to 115 amino acids of Gal-3 fused with Â2EGFP (1-115/Â2GFP) and 139 to 193 amino acids fused with GST and EGFP (GST/139-193/GFP) were constructed and used as import substrates using the in vitro transport assay.
As shown in Fig. 5 , the 1-115/Â2GFP protein was evenly distributed in the nucleus with or without cytosol and/or ATP in the reaction mixture (Fig. 5A-C) , whereas its nuclear accumulation was inhibited by the addition of WGA (Fig. 5D) . However, the GST/ 139-193/GFP protein, under any solution condition, could not be detected in any significant level in the nucleus and was predominantly confined to the cytoplasmic compartment ( Fig.  5E-H) . It should also be noted that nuclear accumulation of GST/ 139-193/GFP protein was partially observed in the presence of cytosol and sucrose (control; Fig. 5E ), and was not detected in the presence of lactose (Fig. 5K) , suggesting that Gal-3 may also translocate into the nucleus by carrier protein system through its h-galactoside binding domain. The 1-115/Â2GFP protein was imported to the nucleus more effectively compared with the GST/ 139-193/GFP protein; therefore, we may conclude that the NH 2 -terminal region of Gal-3 protein is significantly involved in the nuclear translocation of Gal-3.
Because the NH 2 -terminal regulation of Gal-3 migration into the nucleus is independent of cytosol and ATP, similarly to the importin-h and h-catenin nuclear import pathway (29, 33, 34) , we questioned whether the active transport pathway of Gal-3 is, in part, dependent on a similar nuclear import pathway of importinh. To address this, we have done competitor experiments in the digitonin-permeabilized cells using cytosol, which contains low (1 mg/mL) or high (10 mg/mL) concentrated soluble cytoplasmic proteins, or recombinant importin-h protein fused to GST (2 Amol/L). As shown in Fig. 6A , GFP/imp-h nuclear accumulation was significantly inhibited by the addition of a high protein concentration (Fig. 6A, c) or a nontagged recombinant importin-h (Fig. 6A, d) . However, neither Gal-3/GFP nor 1-115/Â2GFP nuclear accumulation were inhibited by the addition of cytosol or excess importin-h protein (Fig. 6A , e-h, i-l), suggesting that the Gal-3 transversing through the NPC passage is distinct from that of importin-h. Next, we examined whether Gal-3 could directly interact with an FG repeat motif of nucleoporins and considered as common docking sites for proteins like importin-h during passage though the NPC (25, 35) . To address this, we have constructed a fusion protein, GST, and an FG repeat containing fragment of human nucleoporin CAN/Nup214(FG-repeat) as previously described (25) , and did GST pull-down assay followed by Western blotting of GFP. As shown in Fig. 6B , GFP/imp-h complexed with FG repeat, but did not bind to GST (CTRL), consistent with the previous report (25) indicating that this FG repeat motif was properly expressed and importin-h can interact with this motif. In contrast, neither Gal-3/GFP nor 115/Â2GFP could bind to FG repeat (Fig. 6B, CTRL) . We also confirmed the same results by Western blotting of importin-h and Gal-3 (data not shown), suggesting that Gal-3 nuclear accumulation is not saturable and its nuclear import pathway is independent on an FG repeat region of the nucleoporins.
Nuclear export of Gal-3. The above data show that Gal-3 possesses the ability to migrate into the nucleus constitutively through at least two pathways. However, Gal-3 is not exclusively localized in the nucleus due to Gal-3 nuclear export system (5, 20) . This export mechanism was better characterized using the digitonin-permeabilized cells and it was speculated that this export was regulated by NES in the COOH-terminal region of Gal-3 (Gal-3 NES; Fig. 7A; ref. 20) . Therefore, we questioned whether this leucine-rich motif could actually serve as a typical NES. To address this, we constructed an expression vector of Â2EGFP fused with Gal-3 NES or p53NES2 (Fig. 7A) , expressed them in the COS-7 cells, and followed their nuclear accumulation with or without LMB, which inhibits the interaction between NES and CRM1 export receptor (36, 37) . In addition, we examined the nuclear accumulation of Gal-3/GFP and Â2GFP with or without LMB as well. To confirm the correct expression of those proteins, we did Western blotting of GFP using COS-7 cell lysates transfected with the plasmids as shown in Fig. 7B . Thereafter, LMB treatment was done to the transiently transfected COS-7 cells at 30 ng/mL (4 hours at 37jC) and to cells were incubated with DMSO vehicle, control. At the end of the incubation, cells were processed for fluorescence microscopy analysis. The representative images are shown in Fig. 7C and the relative proportion of distinct subcellular localization in each plasmid transfected COS-7 cells is depicted in Fig. 7D . The expression pattern of Â2GFP was not affected by the LMB treatment, and the proteins were distributed throughout the cell (Fig. 7C, a, e and D) , whereas the expression of 1-250/G was effectively accumulated in the nucleus following LMB treatment (Fig. 7C, b, f and D) . This result is consistent with previous reports (20) . Meanwhile, the expression of Gal-3NES+Â2GFP as well as p53NES2+Â2GFP was restricted to the nucleus with LMB treatment compared with no treatment (Fig. 7C, c, g, d, h and D) . These results suggest that Gal-3 NES can play a role in the nuclear export of Gal-3 as a bona fide NES and this export system can also regulate the nuclear localization of Gal-3 protein in vivo.
Discussion
Gal-3 plays a central role in diverse biological functions, including regulation of cell adhesion, proliferation, differentiation, angiogenesis, antiapoptotic activity, and RNA processing activity in juxtaposition with its interacting ligands that specify function (2, 5, 38) . In the nucleus, Gal-3 is thought to play a role in pre-mRNA splicing (39) , and regulation of gene expression of cyclin D1 and cmyc (15, 16) . Therefore, the unveiling the mechanism of Gal-3 shuttling to and from the nucleus is very significant as it might be developed as a therapeutic modality to inhibit and/or regulate gene expression related to cancer. To date, the mechanism of Gal-3 nuclear import is not implicit, due, in part, to the fact that Gal-3 lacks a consensus NLS and the obtained information are based mainly on indirect evidences. Several reports have identified the domain(s) sequences of Gal-3 for its nuclear localization by transfection techniques (21) (22) (23) . Previously, a role for the NH 2 -terminal region of Gal-3 for its nuclear localization was suggested (21) , whereas others have argued that its NH 2 terminus is not involved for its nuclear localization (22) , and that the last 10 amino acids of the COOH-terminal region of Gal-3 are responsible for its nuclear transport properties (23) . These contradictory findings may be due to the lack of a direct experimental evidence for the Gal-3 nuclear import mechanism and whether it results from passive diffusion or active transport. Thus, we examined the cellular distribution of various deletion mutants of human Gal-3 by transfection to check the essential domain for its nuclear localization in vivo, and did in vitro nuclear import assay necessary to direct evidence for Gal-3 nuclear import mechanism(s). In vivo, the last 10 amino acid deletion (1-240/G) dramatically abrogated the nuclear localization of Gal-3 as described recently (23) , but a complete CRD region-deleted Gal-3 (1-115/G, 1-115/Â3GFP), in turn, was predominantly localized in the nucleus. However, it should be noted that all these results could not directly provide the nuclear import mechanism and the observed result is the balance between cytoplasmic anchorage, nuclear import, nuclear retention, and nuclear export (23) . Therefore, an in vitro nuclear import assay to directly assess the nuclear import mechanism of Gal-3 was used and constructed Gal-3 protein that was conjugated with fluorescent material (F/Gal-3).
Gal-3 translocates into the nucleus by an active nuclear import mechanism as shown here, and the NH 2 -terminal domain of Gal-3 protein plays a significant role in its NPC passage; this domain contains a glycine, tyrosine, and proline repeat motif and is critical for molecule self-association (40) . Independently, it has been reported that NPC has a similar repeat motif, such as an FG repeat or a WD repeat, that are used for the interaction with the nucleoproteins for their NPC passage (41, 42) . We cannot exclude the possibility of another Gal-3 nuclear import pathway, through its carbohydrate-binding capacity, because the results from the in vivo and the in vitro experiments suggest that 139 to 193 amino acid motif of the human Gal-3 could be translocated into the nucleus by a soluble factor (Figs. 2C, i and 5E).
Here, we revealed at least two mechanisms responsible for the nuclear import of Gal-3 similarly to other proteins. RCC1, the Ran exchange factor, uses two distinct nuclear import mechanisms (43) . MAPK uses at least three distinct pathways: passive diffusion as a monomer, active transport as a dimer, and an NPC-mediated pathway (25, 44) . Correspondingly, Gal-3 might be imported into the nucleus by passive diffusion as a monomer, and it is also possible for several Gal-3 to be imported by active transport as a dimer (40) or a pentamer formation (45) .
It is crucial to point out that 1-240/G or 1-250/Â3GFP failed to localize in the nucleus in vivo, which contain the NH 2 -terminal region promoting the nuclear migration in vitro. Concerning these phenomena, it would be worth mentioning the speculations by Davidson et al. (23) , who have reported and discussed the importance of the COOH-terminal region of murine Gal-3 for nuclear localization (46) . The CRD region of Gal-3 is composed of two h-pleated sheets associated in a sandwich-like arrangement, one of which contains five antiparallel strands (F1-5) and the other contains six antiparallel strands (S1-6). They speculated that the deletion of the last 10 amino acids, which compose the F1 strand, could unravel the h-sandwich structure, followed by the impaired nuclear localization (23) . However, it should be pointed out that the crystal structure of whole Gal-3 is not available and reliance on part of the structure might be misleading. Based on the result presented here, we suggest that this impaired nuclear accumulation could be caused due to the protein aggregation following the disruption of the h-sandwich structure because the expression of defective Gal-3 showed a patchy vesicular pattern and is spotted in the perinuclear region (Figs. 1C, d, e and 2C, d) . This alteration should be more inducible and rapid compared with the nuclear import efficiency of Gal-3, but not to the nuclear import capacity of a typical NLS because SV40 T-antigen NLS could effectively rescue the nuclear accumulation of impaired Gal-3 (Fig. 3C, D) .
To conclude, we provide here the first direct evidence for the nuclear transport of Gal-3 and show that it is regulated by complicated mechanisms of balance between cytoplasmic anchorage, nuclear import (passive diffusion and active), nuclear retention, and nuclear export.
